USGA heute +40%, wer weiß mehr - 500 Beiträge pro Seite

[Tom02]

Was ist mit USGA los, wer hat Informationen?

[cbeck]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 17, 2005


US GLOBAL NANOSPACE, INC.
(Exact name of registrant as specified in its charter)


Delaware 000 - 23339 13-3720542
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)


2533 North Carson Street, Suite 5107 89706
Carson City, Nevada
(Address of principal executive offices) (Zip Code)

Registrant`s telephone number, including area code [phone]

--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)

[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))



<PAGE>

This Form 8-K and other reports filed by US Global Nanospace, Inc. (the
"Registrant") from time to time with the Securities and Exchange Commission
(collectively the "Filings") contain forward looking statements and information
that are based upon beliefs of, and information currently available to, the
Registrant`s management as well as estimates and assumptions made by the
Registrant`s management. When used in the Filings the words "anticipate",
"believe", "estimate", "expect", "future", "intend", "plan" or the negative of
these terms and similar expressions as they relate to the Registrant or the
Registrant`s management identify forward looking statements. Such statements
reflect the current view of the Registrant with respect to future events and are
subject to risks, uncertainties, assumptions and other factors relating to the
Registrant`s industry, operations and results of operations and any businesses
that may be acquired by the Registrant. Should one or more of these risks or
uncertainties materialize, or should the underlying assumptions prove incorrect,
actual results may differ significantly from those anticipated, believed,
estimated, expected, intended or planned.

Item 8.01 Other Events.

On November 14, 2005 the Registrant received confirmation from Kidde
Firefighting, Inc. ("Kidde"), a subsidiary of United Technologies Corporation
(NYSE: UTX)("UTC"), that Kidde has filed with the US Environmental Protection
Agency ("EPA") an application for registration as a disinfectant and sterilant
(sporicidal) of the ALL-CLEAR(TM) Chemical and Biological Agent Decontamination
Foam product ("All-Clear") developed by the Registrant and Kidde. The EPA
application is premised upon the All-Clear formulation being a low-toxicity,
non-corrosive liquid foaming agent for decontaminating a broad range of chemical
and biological hazards. All-Clear is not currently available for sale in the
United States or to any organization subject to EPA regulations.

All-Clear is an enzyme and biocide liquid foam mixture that has been shown
effective in tests against chemical nerve agents, bacterial agents (spore and
non spore), viral agents and toxins. All-Clear has been live agent tested at the
Illinois Institute of Technological Research Institute in Chicago, Illinois,
where it tested to be effective against Bacillus Anthracis yielding an effective
kill rating of 99.999999 percent.

All-Clear has passed the AOAC Sporicidal and Use Dilution Tests required
for EPA registration, as conducted by Microbiotest, Inc. in Sterling, Virginia.
In addition, All-Clear has passed the Boeing Series Corrosion Test, as conducted
by Scientific Material International, Inc. in Miami, Florida, making it a
candidate for use on aircraft exteriors or other equipment vulnerable to
existing corrosive decontamination technologies.

Recently, Kidde also affirmed that All-Clear has demonstrated high
efficacy on three additional biological agents: live agent MRSA, SARS and Avian
Influenza. For MRSA (Methicillin Resistant Staphylococcus Aureus), All-Clear was
shown at Huntingdon Life Sciences, Ltd., in the United Kingdom to be an
effective anti-microbial agent in the test procedure including a hard surface
contact test, agar diffusion test and aqueous suspension test. All-Clear also
tested effective at Microbiotest, Inc. on SARS-associated Corona Virus, CDC
strain 200300592 ZepoMetrix and Avian Influenza Virus A2 strain H9N2
Turkey/WIS/66. In these tests, All-Clear achieved the required reduction after
five minutes of exposure to the live agent viruses.

Additional information can be viewed at www.All-Clear.com, a website
maintained by Kidde to provide information about All-Clear to the public. The
contents of this website are not incorporated into this filing. Further, the
Registrant`s reference to the URL for this website is intended to be an inactive
textual reference only.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

US GLOBAL NANOSPACE, INC.
(Registrant)

Date: November 17, 2005 /s/ Carl Gruenler
--------------------------------------
Carl Gruenler, Chief Executive Officer
</TEXT>
</DOCUMENT>

[zillus]

hab auch schon einen thread eröffnet, aber keiner meldet sich ---war schon beim letzten Anstieg dabei und habe schon wieder mittelfett eingesammelt--rein charttechnisch !!!---beim nächsten nanoboom gehen die ab !!!

[marterpfahl]

Press Release Source: US Global Nanospace


US Global Nanospace Launches MAPSANDS(TM)
Monday December 5, 11:57 pm ET


New System Delivers Autonomous Wide-Area Perimeter Security & Defense


CARSON CITY, NV--(MARKET WIRE)--Dec 5, 2005 -- US Global Nanospace, Inc. (OTC BB:USGA.OB - News) ("USGN") announced today that it has launched MAPSANDS(TM) -- Modular Autonomous Perimeter Security and Non-Lethal Defense System. The USGN team, consisting of its employees and certain independent contractors, designed MAPSANDS(TM) to address the need for autonomous wide-area perimeter security and access denial for sovereign borders, pipelines, power plants, seaports, ships, airports, oil and gas refineries, offshore oil rigs and other high value infrastructure.
ADVERTISEMENT


In June 2004, USGN filed a provisional patent application, and in June 2005 a utility patent application, with the U.S. Patent and Trademark Office for the entire MAPSANDS(TM) system. MAPSANDS(TM) combines USGN-developed proprietary, secure and robust control software plus advanced wireless communications and remote power systems with detection and tracking sensors, directed energy acoustics and a suite of accurately delivered non-lethal munitions. Unlike traditional perimeter security solutions, the MAPSANDS(TM) system architecture was designed to secure perimeters ranging in length from less than one mile to several hundred continuous miles and to deliver a programmed response based on predetermined rules of engagement.

MAPSANDS(TM) relies on advanced radars capable of detecting, tracking and targeting to aim directional acoustic devices delivering clear verbal warnings and aversive warning tones to area perimeter intruders. These powerful acoustic devices are designed to be effective at operationally significant ranges to help determine an approaching intruder`s intent and affect the intruder`s behavior. In the event an area perimeter intruder fails to heed the increasingly threatening acoustic warnings delivered by MAPSANDS(TM), the system can be programmed to accurately and autonomously target and disperse non-lethal deterrent munitions, such as flash bang, tear gas, malodorants, or rubber pellets to establish a pre-set area denial perimeter. A variety of advanced lethal or non-lethal munitions delivery options are available based on customer specifications and rules of engagement, subject to compliance with applicable laws, treaties and regulations. Continuous remote location power, another key element of the system, is supplied through advanced, highly reliable solar and wind power configurations developed by an independent contractor of USGN that has installed solar and wind power systems in over 50 countries in some of the harshest environments on earth.

"Until today, perimeter protection really meant perimeter breach notification and dispatching a response team. MAPSANDS(TM) is designed to automatically protect and defend high-value remote installations with or without human intervention, eliminating the issues of inadequate manpower or misplaced loyalty that have plagued existing wide-area security endeavors," stated Carl Gruenler, Chief Executive Officer of USGN. "We are now able to conduct mobile demonstrations of MAPSANDS(TM) and its capabilities to potential customers. Also, we plan to continue expanding our technology partnerships to help maximize customer-driven flexibility and address multiple mission objectives."

`"No single technology can eliminate the vulnerabilities in today`s complex security environment," continued Mr. Gruenler. "That`s why it is so important to adopt a holistic approach to security, one that can address the complexity and scale of today`s most challenging security needs by incorporating multiple, coordinated technologies that are capable of operating autonomously under a common set of user-defined protocols."

USGN has established sales representation for MAPSANDS(TM) in the Middle East Gulf Cooperation Council countries, and is currently evaluating potential sales representatives for North America, Asia and Europe. Going forward, in connection with MAPSANDS(TM), USGN plans to focus on software development, systems integration, new technology development and sourcing system components from independent contractors. Subject to compliance with domestic and international laws and regulations, or treaties, USGN hopes to enter into licensing or other business arrangements with one or more companies that have the financial resources, contacts and expertise needed to effectively market, sell and maintain MAPSANDS(TM) installations on a commercial scale worldwide.

More information about MAPSANDS(TM) can be found on the updated US Global Nanospace website, www.usgn.com, including pictures of the mobile demonstration equipment.

About US Global Nanospace

US Global Nanospace, Inc. is a solutions oriented research and development company that specializes in identifying, developing, and commercializing new and emerging technologies and products for integration into the security, defense and health and safety markets. USGN uses cross-discipline knowledge in the areas of science, engineering, nanotechnology and nanomaterials to evolve products that address high performance issues. USGN has focused its commercial efforts on identifying strategic partnership companies that have the resources to manufacture, market or integrate its products on a commercial scale. USGN`s products include MAPSANDS(TM), All-Clear(TM) Chem/Bio Decontamination Foam, the G-Lam line of variable threat armor solutions, NanoFilters for HVAC, NanoFilterCX, BlastX, and Radomes. More information is available at http://www.usgn.com.

Safe Harbor

This announcement contains express or implied forward-looking statements about US Global Nanospace`s future financial and operating results, products and business relationships. These statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those suggested in the forward-looking statements, including but not limited to, reliance on the manufacturing, sales and marketing efforts of a third party over which US Global Nanospace has no direct control, enforceability, and validity of proprietary rights, ability to raise sufficient capital or borrow sufficient funds to fund future operations, ability to develop future products, technology shifts, potential technical or manufacturing difficulties that could delay products, competition, pricing pressures, the uncertainty of market acceptance of new products by customers, the outcome of pending or future litigation, ability to obtain and maintain regulatory approvals for products, general economic factors and other risks identified and discussed in US Global Nanospace`s filings with the Securities and Exchange Commission, including those set forth in US Global Nanospace`s annual report on Form 10-KSB before the year ended March 31, 2005. These forward-looking statements are based on information and management`s expectations as of the date hereof. Future results may differ materially from the US Global Nanospace`s current expectations. US Global Nanospace disclaims any intent or obligation to update those forward-looking statements, except as required by law.



Contact:
Contacts:
Amy Power
Office: 214.618.3318
Mobile: [phone]
Email Contact

Troy Scheer
Office: 972-323-0491
Mobile: [phone]
Email Contact



--------------------------------------------------------------------------------
Source: US Global Nanospace